Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen

Instituto de Reabilitacao de Campinas, Universidade Estadual de Campinas, Sao Paulo, Brazil.

This case report describes an 11-year-old boy with spastic diplegia whose reflex status, range of motion (ROM), strength, and motor performance were measured before and after implantation of an indwelling system for delivery of intrathecally administered baclofen. Before baclofen use, the subject experienced clonus that interfered with walking, needed assistance with transfers, and was unable to independently put on underwear and socks. Measures of spasticity, kinematics and electromyographic activity during voluntary movements, ROM, Gross Motor Function Measure (GMFM) scores, and self-reports of change were obtained at baseline, before and after bolus baclofen injection, during a double-blind placebo-controlled clinical trial of baclofen administration via an indwelling pump, and after 1 and 2 years of baclofen therapy. Spasticity, Babinski reflexes, clonus, strength, and coactivation of antagonist muscles during voluntary movement were decreased shortly after baclofen administration began. Hip and ankle ROM increased, upper-extremity movement speed increased, independence in dressing and transfers improved, and orthoses were discarded. After 1 and 2 years, GMFM scores were 7.8% and 6.4% above baseline, respectively; the subject won a fitness award. After 2 years, ROM was worse than at baseline and concerns regarding hip subluxation arose. Single-joint movement control and independence improved and spasticity decreased during baclofen administration.

This article has been cited by other articles:

				G. de Lissovoy, L. S. Matza, H. Green, M. Werner, and T. Edgar Cost-effectiveness of Intrathecal Baclofen Therapy for the Treatment of Severe Spasticity Associated With Cerebral Palsy J Child Neurol, January 1, 2007; 22(1): 49 - 59. [Abstract] [PDF]

				S. K Campbell Are Models of Disability Useful in Real Cases? Pediatric Case Examples Realized in Research, Clinical Practice, and Education Physical Therapy, June 1, 2006; 86(6): 881 - 887. [Abstract] [Full Text] [PDF]

				B. L Tieman, R. J Palisano, E. J Gracely, and P. L Rosenbaum Gross Motor Capability and Performance of Mobility in Children With Cerebral Palsy: A Comparison Across Home, School, and Outdoors/Community Settings Physical Therapy, May 1, 2004; 84(5): 419 - 429. [Abstract] [Full Text] [PDF]

				P. Rosenbaum Controversial Treatment of Spasticity: Exploring Alternative Therapies for Motor Function in Children With Cerebral Palsy J Child Neurol, January 1, 2003; 18(1_suppl): S89 - S94. [Abstract] [PDF]

				P. L. Rosenbaum, S. D. Walter, S. E. Hanna, R. J. Palisano, D. J. Russell, P. Raina, E. Wood, D. J. Bartlett, and B. E. Galuppi Prognosis for Gross Motor Function in Cerebral Palsy: Creation of Motor Development Curves JAMA, September 18, 2002; 288(11): 1357 - 1363. [Abstract] [Full Text] [PDF]

				D. J Bartlett and R. J Palisano Physical Therapists' Perceptions of Factors Influencing the Acquisition of Motor Abilities of Children With Cerebral Palsy: Implications for Clinical Reasoning Physical Therapy, March 1, 2002; 82(3): 237 - 248. [Abstract] [Full Text] [PDF]

				D. J Russell, L. M Avery, P. L Rosenbaum, P. S Raina, S. D Walter, and R. J Palisano Improved Scaling of the Gross Motor Function Measure for Children With Cerebral Palsy: Evidence of Reliability and Validity Physical Therapy, September 1, 2000; 80(9): 873 - 885. [Abstract] [Full Text] [PDF]

				V. Mall, F. Heinen, J. Kirschner, M. Linder, S. Stein, U. Michaelis, P. Bernius, M. Lane, and R. Korinthenberg Evaluation of Botulinum Toxin A Therapy in Children With Adductor Spasm by Gross Motor Function Measure J Child Neurol, April 1, 2000; 15(4): 214 - 217. [Abstract] [PDF]